HeartBeam (BEAT) EBITDA (2020 - 2026)

HeartBeam (BEAT) has reported EBITDA for 7 consecutive years, with -$5.1 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, EBITDA fell 1.09% year-over-year to -$5.1 million in Q2 2026; TTM through Jun 2026 was -$20.4 million, a 0.71% increase from a year earlier, with the FY2025 full-year figure at -$21.1 million, down 6.3% from the prior year.
• EBITDA was -$5.1 million for Q2 2026 at HeartBeam, down from -$4.7 million in the prior quarter.
• Over five years, EBITDA peaked at -$2.1 million in Q1 2022 and troughed at -$5.5 million in Q1 2025.
• A 5-year average of -$4.4 million and a median of -$4.8 million in 2024 frame the typical range for EBITDA.
• Across the five-year window, EBITDA sank 1217.79% in 2022 and advanced 14.32% in 2026, its largest moves.
• Over 5 years, EBITDA stood at -$3.7 million in 2022, then slipped by 9.9% to -$4.1 million in 2023, then decreased by 20.32% to -$4.9 million in 2024, then fell by 7.4% to -$5.3 million in 2025, then gained by 4.11% to -$5.1 million in 2026.
• The last three EBITDA figures came in at -$5.1 million (Q2 2026), -$4.7 million (Q1 2026), and -$5.3 million (Q4 2025), per Business Quant data.